FDAnews Announces — European Drug Assessment Policy for Biological...

Some biologics makers may view the EU’s new CMC policy as a hurdle. Here’s why it’s also a golden sales opportunity.(PRWeb November 16, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14929672.htm

Source: PRWeb: Medical Pharmaceuticals - November 16, 2017 Category: Pharmaceuticals Source Type: news